Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page. This appears to be a minor metadata update rather than substantive changes to study information.SummaryDifference0.1%

- Check20 days agoChange DetectedA new publication entry from Circulation (2025) related to the DAPA ACT HF-TIMI 68 trial was added to the Publications section, and the Publications note now states entries are automatically filled from PubMed.SummaryDifference0.2%

- Check27 days agoChange DetectedRemoval of a site-wide notice about government funding and NIH operating status from the page. This change affects messaging only and does not modify the study details, locations, eligibility criteria, or outcomes.SummaryDifference0.4%

- Check41 days agoChange DetectedNo substantive changes detected; the Study Details page content remains the same aside from minor formatting differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check70 days agoChange DetectedAdditions introduce a government-operating-status notice and upgrade to v3.2.0; deletions remove the previous v3.1.0 version tag.SummaryDifference4%

- Check77 days agoChange DetectedAdds version label v3.1.0 and removes multiple drug-safety topics, indicating a content scope shrink and a new versioning update.SummaryDifference0.5%

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.